John Poyhonen

Track

Insider profile

Currently holds a position at Heron Therapeutics Inc

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President, Chief Commercial Officer, Director Heron Therapeutics Inc July 15, 2019 -
Independent Director Heron Therapeutics Inc Jan. 10, 2014 - July 15, 2019
President, Chief Executive Officer, Director Senomyx Inc Jan. 2, 2014 - Nov. 2, 2018
President, Chief Operating Officer Senomyx Inc Sept. 24, 2009 - Jan. 2, 2014
Independent Director Ardea Biosciences Inc June 15, 2007 - June 19, 2012
John Poyhonen's trades of Heron Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
488.81
Quantity 71,037 +20.9%
Value US$1,008,036
Transaction date
Purchase
Price
316.89
Quantity 17,722 +49.7%
Value US$2,754,936
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2019-10-04 2019-10-03
B Purchase
71,037 +20.9%
488.81
US$1,008,036 		71,037 +20.9% 488.81 US$1,008,036
2019-05-23 2019-05-22
B Purchase
17,722 +49.7%
316.89
US$2,754,936 		17,722 +49.7% 316.89 US$2,754,936